Related Experiment Video
Updated: May 31, 2025
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Data Mining Models in Prediction of Vancomycin-Intermediate Staphylococcus aureus in Methicillin-Resistant S. aureus
Wei-Chuan Chen1,2,3, Jiun-Ling Wang4,5, Chi-Chuan Chang1
1Division of Teaching and Education, Teaching and Research Department, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.
Abstract:
Vancomycin-intermediate Staphylococcus aureus (VISA) is a multi-drug-resistant pathogen of significant clinical concern. Various S. aureus strains can cause infections, from skin and soft tissue infections to life-threatening conditions such as bacteremia and pneumonia. VISA infections, particularly bacteremia, are associated with high mortality rates, with 34% of patients succumbing within 30 days. This study aimed to develop predictive models for VISA (including hVISA) bacteremia outcomes using data mining techniques, potentially improving patient management and therapy selection. We focused on three endpoints in patients receiving traditional vancomycin therapy: VISA persistence in bacteremia after 7 days, after 30 days, and patient mortality. Our analysis incorporated 29 risk factors associated with VISA bacteremia. The resulting models demonstrated high predictive accuracy, with 82.0-86.6% accuracy for 7-day VISA persistence in blood cultures and 53.4-69.2% accuracy for 30-day mortality. These findings suggest that data mining techniques can effectively predict VISA bacteremia outcomes in clinical settings. The predictive models developed have the potential to be applied prospectively in hospital settings, aiding in risk stratification and informing treatment decisions. Further validation through prospective studies is warranted to confirm the clinical utility of these predictive tools in managing VISA infections.
Insights
Data mining models accurately predict outcomes for vancomycin-intermediate Staphylococcus aureus (VISA) bacteremia. These tools can improve patient risk stratification and guide treatment decisions for this serious infection.
Area of Science:
- Infectious Diseases
- Medical Informatics
- Computational Biology
Background:
- Vancomycin-intermediate Staphylococcus aureus (VISA) is a multidrug-resistant pathogen causing severe infections, including bacteremia with high mortality rates.
- VISA bacteremia poses a significant clinical challenge, necessitating improved methods for outcome prediction and patient management.
- Current treatment strategies for VISA infections often rely on vancomycin, but predicting patient response remains difficult.
Purpose of the Study:
- To develop and validate predictive models for vancomycin-intermediate Staphylococcus aureus (VISA) bacteremia outcomes using data mining techniques.
- To identify key risk factors associated with VISA bacteremia persistence and patient mortality.
- To enhance clinical decision-making and patient stratification for VISA infections.
Main Methods:
- Utilized data mining techniques to analyze clinical data from patients with VISA bacteremia.
- Incorporated 29 identified risk factors into the predictive models.
- Focused on predicting three key endpoints: VISA persistence in blood cultures at 7 days, VISA persistence at 30 days, and 30-day patient mortality.
Main Results:
- Developed predictive models with high accuracy for VISA bacteremia outcomes.
- Achieved 82.0-86.6% accuracy in predicting 7-day VISA persistence in blood cultures.
- Demonstrated 53.4-69.2% accuracy in predicting 30-day mortality for patients with VISA bacteremia.
Conclusions:
- Data mining offers a powerful approach for predicting VISA bacteremia outcomes.
- The developed models show potential for clinical application in risk stratification and treatment selection.
- Further prospective studies are recommended to validate the clinical utility of these predictive tools.
